Yahoo Web Search

Search results

  1. 1 day ago · Use of semaglutide 1.0 mg (Ozempic) offers benefits on cardiovascular outcomes, regardless of baseline chronic kidney disease severity, according to an analysis of the FLOW trial presented at the European Society of Cardiology (ESC) Congress 2024. Presented by Kenneth Mahaffey, MD, professor of Medicine at Stanford University, less than 4 ...

  2. 2 days ago · The IMT studies showed significantly improved fatigue (MD = −11.36, 95%CI = −15.30 to −7.41, p < .00001, I2 = 54%). However, three studies, with moderate heterogeneity (p = .10, I2 = 56%), showed non-significant changes in HR-QoL (SMD = −0.04, 95% CI = −.45 to .37, p = .83).

  3. 2 days ago · Liu J, Mozaffarian D. Trends in diet quality among U.S. adults from 1999 to 2020 by race, ethnicity, and socioeconomic disadvantage. Ann Intern Med 2024;177: 841-50. Brandt EJ, Chang T, Leung C, et al. Food insecurity among individuals with cardiovascular disease and cardiometabolic risk factors across race and ethnicity in 1999-2018.

  4. 1 day ago · The abovementioned has been recently extensively discussed in a study by Harb et al., 6 published in European Heart Journal Open (EHJ Open) simultaneously with the European Society of Cardiology (ESC) Congress 2024 presentation in London. The authors aimed to determine, in a retrospective analysis with 609 individuals in the Nashville Biosciences database, the intraindividual variability of Lp ...

  5. 3 days ago · Although the mortality rate associated with coronary artery disease (CAD) has exhibited a relative declined over the past decade, it remains a prominent global cause of death that imposes significant personal, economic, and societal burdens.1 Previous studies have demonstrated that managing low-density lipoprotein cholesterol (LDL-C) levels is crucial in patients with CAD.2 For individuals ...

  6. 2 days ago · In this prospective cohort study involving middle-aged and older adults with type 2 diabetes, comprehensive risk-factor control was associated with a 67.0% lower risk of incident heart failure during a median follow-up period of 12.3 years.

  7. 5 days ago · In the 2014 HRS Expert Consensus Statement, ICD implantation carries a class IIb indication in patients with LVEF 36-49%. The 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death provides a class IIa recommendation for ICD implantation in CS patients with LVEF >35% on the basis of history of syncope, presence of scar on ...

  1. People also search for